Exagen Inc (XGN)
1.895
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
1.895
0.00 (0.00%)
After-Hours: 20:00
Exagen Total Liabilities (Quarterly): 30.82M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 30.82M |
December 31, 2023 | 34.25M |
September 30, 2023 | 33.42M |
June 30, 2023 | 32.28M |
March 31, 2023 | 43.30M |
December 31, 2022 | 43.76M |
September 30, 2022 | 45.41M |
June 30, 2022 | 43.54M |
March 31, 2022 | 45.89M |
December 31, 2021 | 38.51M |
September 30, 2021 | 36.97M |
June 30, 2021 | 36.94M |
March 31, 2021 | 36.05M |
December 31, 2020 | 36.54M |
September 30, 2020 | 35.52M |
Date | Value |
---|---|
June 30, 2020 | 32.67M |
March 31, 2020 | 34.11M |
December 31, 2019 | 32.65M |
September 30, 2019 | 34.09M |
June 30, 2019 | 33.80M |
December 31, 2018 | 35.62M |
December 31, 2015 | 36.81M |
September 30, 2015 | 34.40M |
June 30, 2015 | 31.49M |
March 31, 2015 | 33.23M |
December 31, 2014 | 31.20M |
September 30, 2014 | 28.60M |
June 30, 2014 | 22.35M |
December 31, 2013 | 16.00M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
30.82M
Minimum
Mar 2024
45.89M
Maximum
Mar 2022
37.03M
Average
35.79M
Median
Total Liabilities (Quarterly) Benchmarks
Fonar Corp | 52.60M |
XWELL Inc | 18.02M |
ProPhase Labs Inc | 45.16M |
Applied DNA Sciences Inc | 9.351M |
Veracyte Inc | 81.42M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 50.81M |
Shareholders Equity (Quarterly) | 19.99M |
Debt to Equity Ratio | 0.9773 |
Current Ratio | 4.828 |
Net Debt Paydown Yield | 6.85% |